State of the science on mild cognitive impairment (MCI)

ND Anderson - CNS spectrums, 2019 - cambridge.org
Mild cognitive impairment (MCI) represents a transitional stage between healthy aging and
dementia, and affects 10–15% of the population over the age of 65. The failure of drug trials …

Alzheimer's disease: from firing instability to homeostasis network collapse

S Frere, I Slutsky - Neuron, 2018 - cell.com
Alzheimer's disease (AD) starts from pure cognitive impairments and gradually progresses
into degeneration of specific brain circuits. Although numerous factors initiating AD have …

[HTML][HTML] The aging astrocyte transcriptome from multiple regions of the mouse brain

MM Boisvert, GA Erikson, MN Shokhirev, NJ Allen - Cell reports, 2018 - cell.com
Aging brains undergo cognitive decline, associated with decreased neuronal synapse
number and function and altered metabolism. Astrocytes regulate neuronal synapse …

[HTML][HTML] Arizona study of aging and neurodegenerative disorders and brain and body donation program

TG Beach, CH Adler, LI Sue, G Serrano… - … : official journal of the …, 2015 - ncbi.nlm.nih.gov
Abstract The Brain and Body Donation Program (BBDP) at Banner Sun Health Research
Institute (http://www. brainandbodydonationprogram. org) started in 1987 with brain-only …

Locus coeruleus cellular and molecular pathology during the progression of Alzheimer's disease

SC Kelly, B He, SE Perez, SD Ginsberg… - Acta neuropathologica …, 2017 - Springer
A major feature of Alzheimer's disease (AD) is the loss of noradrenergic locus coeruleus
(LC) projection neurons that mediate attention, memory, and arousal. However, the extent to …

[HTML][HTML] Response of the medial temporal lobe network in amnestic mild cognitive impairment to therapeutic intervention assessed by fMRI and memory task …

A Bakker, MS Albert, G Krauss, CL Speck… - NeuroImage: Clinical, 2015 - Elsevier
Studies of individuals with amnestic mild cognitive impairment (aMCI) have detected
hyperactivity in the hippocampus during task-related functional magnetic resonance imaging …

Golgi fragmentation–One of the earliest organelle phenotypes in Alzheimer's disease neurons

H Haukedal, GI Corsi, VP Gadekar… - Frontiers in …, 2023 - frontiersin.org
Alzheimer's disease (AD) is the most common cause of dementia, with no current cure.
Consequently, alternative approaches focusing on early pathological events in specific …

Synaptic dysfunction in Alzheimer's disease: Mechanisms and therapeutic strategies

Y Chen, AKY Fu, NY Ip - Pharmacology & therapeutics, 2019 - Elsevier
Abstract Alzheimer's disease (AD), the most prevalent neurodegenerative disease in the
elderly population, is characterized by progressive cognitive decline and pathological …

Hippocampal plasticity during the progression of Alzheimer's disease

EJ Mufson, L Mahady, D Waters, SE Counts, SE Perez… - Neuroscience, 2015 - Elsevier
Neuroplasticity involves molecular and structural changes in central nervous system (CNS)
throughout life. The concept of neural organization allows for remodeling as a compensatory …

Functional excitatory to inhibitory synaptic imbalance and loss of cognitive performance in people with Alzheimer's disease neuropathologic change

P Scaduto, JC Lauterborn, CD Cox, A Fracassi… - Acta …, 2023 - Springer
Individuals at distinct stages of Alzheimer's disease (AD) show abnormal
electroencephalographic activity, which has been linked to network hyperexcitability and …